Melatonin is widely used and generally perceived as a safe and effective sleep aid, though notable variations in dosing, reliance, and misuse exist across demographic groups.
In a cross-sectional study of 335 adults in Baghdad, Iraq, 83.8% of participants agreed that melatonin improved their sleep quality, 78.2% considered it safe, and 75.6% recommended it to others. The most common dose was 5 mg (33.6%), and 56.5% used melatonin as needed. Side effects were common, with drowsiness (28.8%) and headache (25.1%) reported, and only 1.5% had no side effects.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Melatonin is widely used and generally perceived as a safe and effective sleep aid, though notable variations in dosing, reliance, and misuse exist across demographic groups. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Melatonin is widely used and generally perceived as a safe and effective sleep aid, though notable variations in dosing, reliance, and misuse exist across demographic groups.
This conclusion is most relevant to: Adults using melatonin recruited from community pharmacies in Baghdad, Iraq (mean age 28.54 ± 10.4 years, 59% female).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸ASSESSMENT OF MELATONIN USE PATTERNS, SAFETY, AND ATTITUDES TOWARD ITS USE IN ADULT POPULATION. (Georgian medical news, 2026) —
How It Works
The proposed biological pathway:
- ▸Melatonin is a neurohormone that regulates sleep
- ▸It is used as a dietary supplement for insomnia and sleep disorders
- ▸Users perceive it as effective and safe, leading to widespread use
- ▸Inappropriate use and side effects (drowsiness, headache) are reported, indicating need for education
Who Might Benefit
Evidence fit by population:
- ▸Adults using melatonin recruited from community pharmacies in Baghdad, Iraq (mean age 28.54 ± 10.4 years, 59% female)
Recommended Dose
Most common dose was 5 mg (33.6% of users)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Cross-sectional design limits causal inference
- ▸Convenience sampling from community pharmacies may introduce selection bias
- ▸Reliance on self-reported data may be subject to recall bias
- ▸Study conducted in a single city (Baghdad) limiting generalizability
Frequently Asked Questions
What is the most common dose of melatonin used by adults in this study?▼
The most common dose was 5 mg, used by 33.6% of participants.
What side effects were reported with melatonin use?▼
The most common side effects were drowsiness (28.8%) and headache (25.1%), with only 1.5% reporting no side effects.
How do users perceive melatonin's effectiveness and safety?▼
83.8% agreed that melatonin improved their sleep quality, 78.2% considered it safe, and 75.6% recommended it to others.
What demographic factors were associated with melatonin use patterns?▼
Age was significantly associated with relying on melatonin for sleep, while sex was correlated with the belief that melatonin is safe. Working and educational status were correlated with willingness to recommend melatonin and reliance on it.
References
- 1.Ahmed F. “ASSESSMENT OF MELATONIN USE PATTERNS, SAFETY, AND ATTITUDES TOWARD ITS USE IN ADULT POPULATION..” Georgian medical news, 2026. PMID: 42600608